| Indicators | Browse All

OraSure Technologies, Inc. (OSUR)

Healthcare | Medical Instruments & Supplies | Bethlehem, United States | NasdaqGS
4.30 USD +0.01 (0.116%) ⇧ (July 13, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:21 a.m. EDT

The investment case for OraSure is currently broken by a severe deterioration in business fundamentals. The company is generating negative operating cash flow (-$43M) and negative free cash flow (-$9M), while revenue has contracted by nearly 7% year-over-year. This operational rot is reflected in the balance sheet, which shows a massive gap between liabilities and equity, resulting in a negative return on equity of roughly 21%. While the stock trades at a discount to book value, this is a 'value trap' driven by insolvency risks rather than a margin of safety; the market is correctly pricing the business as failing. The price action confirms this distress. Over the last nine years, the stock has lost more than half its value, and the trailing twelve months have seen two consecutive years of decline. The recent price action shows a fragile recovery attempt, but the underlying economics remain dire. Short-term, the sentiment is overwhelmingly bearish. Options data reveals a distinct 'put wall' at $2.50, with implied volatility for downside protection nearly four times higher than for upside bets. This suggests institutional hedging or speculative shorting is dominating the flow. The statistical forecasting model offers a negligible 1.4% upside prediction with very low confidence, which aligns with the fundamental reality that there is no catalyst to reverse the trend soon. There is no dividend to provide income, and the capital structure is fragile. Unless there is an immediate turnaround in operations or a strategic acquisition, the trajectory points toward further erosion of shareholder value. The current price is likely a capitulation point rather than a floor.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_79 ✓0.158972
AutoARIMA0.171683
AutoETS0.171684
MSTL0.173077
AutoTheta0.181918
MSTL_79_1260.200871
MSTL_1260.204209

Forecast horizon: 60 days | Selected: MSTL_79

Forecast Reliability
Score 29%
H-stat 77.88
Ljung-Box p 0.000
Jarque-Bera p 0.018
Excess Kurtosis -1.78
Attribute Value
Sector Healthcare
Last Dividend Date 1998-01-07
Debt to Equity Ratio 4.04
Revenue per Share 1.566
Market Cap 296,048,800
Forward P/E -8.55
Beta 1.00
Profit Margins -66.42%
Website https://www.orasure.com

As of July 11, 2026, 3:21 a.m. EDT: Speculators are positioning for continued weakness, evidenced by heavy out-of-the-money put open interest at the $2.50 strike relative to calls. Implied volatility is significantly elevated for puts (3.25%) compared to calls (0.84%), indicating a market pricing in a high probability of further downside or a crash scenario. The lack of call volume beyond the immediate ATM suggests a lack of bullish conviction.


Dividend Data

Dividend History
Date Dividend Yield %
1998-01-08 1.6 30.843373
Additional Data
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 1.6
lastDividendDate 1998-01-08

Info Dump

Attribute Value
52 Week Change 0.40065145
Address1 220 East First Street
All Time High 27.5
All Time Low 1.791667
Ask 5.47
Ask Size 2
Audit Risk 4
Average Daily Volume10 Day 517,800
Average Daily Volume3 Month 648,231
Average Volume 648,231
Average Volume10Days 517,800
Beta 1.004
Bid 3.08
Bid Size 2
Board Risk 3
Book Value 4.515
City Bethlehem
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 1
Country United States
Crypto Tradeable 0
Currency USD
Current Price 4.3
Current Ratio 5.462
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 4.335
Day Low 4.235
Debt To Equity 4.04
Display Name OraSure
Earnings Call Timestamp End 1,778,101,200
Earnings Call Timestamp Start 1,778,101,200
Earnings Timestamp 1,778,097,600
Earnings Timestamp End 1,785,873,600
Earnings Timestamp Start 1,785,873,600
Ebitda -61,541,000
Ebitda Margins -0.54454
Enterprise To Ebitda -2.141
Enterprise To Revenue 1.166
Enterprise Value 131,743,776
Eps Current Year -0.69921
Eps Forward -0.50318
Eps Trailing Twelve Months -1.05
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.812
Fifty Day Average Change 0.48800015
Fifty Day Average Change Percent 0.12801683
Fifty Two Week Change Percent 40.065147
Fifty Two Week High 4.58
Fifty Two Week High Change -0.27999973
Fifty Two Week High Change Percent -0.061135314
Fifty Two Week Low 2.08
Fifty Two Week Low Change 2.2200003
Fifty Two Week Low Change Percent 1.0673078
Fifty Two Week Range 2.08 - 4.58
Financial Currency USD
First Trade Date Milliseconds 532,621,800,000
Float Shares 60,741,636
Forward Eps -0.50318
Forward P E -8.54565
Free Cashflow -8,891,250
Full Exchange Name NasdaqGS
Full Time Employees 500
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.42266998
Gross Profits 47,768,000
Has Pre Post Market Data 1
Held Percent Insiders 0.06382
Held Percent Institutions 0.89115995
Implied Shares Outstanding 68,848,553
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Ir Website http://phx.corporate-ir.net/phoenix.zhtml?c=99740&p=irol-irhome
Is Earnings Date Estimate 1
Language en-US
Last Dividend Date 884,217,600
Last Dividend Value 1.6
Last Fiscal Year End 1,767,139,200
Last Split Date 544,838,400
Last Split Factor 3:1
Long Business Summary OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.
Long Name OraSure Technologies, Inc.
Market us_market
Market Cap 296,048,800
Market State PRE
Max Age 86,400
Message Board Id finmb_540470
Most Recent Quarter 1,774,915,200
Net Income To Common -75,068,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 295,704,535
Number Of Analyst Opinions 2
Open 4.28
Operating Cashflow -43,185,000
Operating Margins -0.78449
Overall Risk 2
Payout Ratio 0.0
Peg Ratio 6.19
Phone 610 882 1820
Previous Close 4.295
Price Eps Current Year -6.149798
Price Hint 4
Price To Book 0.952381
Price To Sales Trailing12 Months 2.619553
Profit Margins -0.66423
Quick Ratio 4.613
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.00500011
Regular Market Change Percent 0.116417
Regular Market Day High 4.335
Regular Market Day Low 4.235
Regular Market Day Range 4.235 - 4.335
Regular Market Open 4.28
Regular Market Previous Close 4.295
Regular Market Price 4.3
Regular Market Time 1,783,972,801
Regular Market Volume 265,847
Return On Assets -0.10646
Return On Equity -0.21158001
Revenue Growth -0.067
Revenue Per Share 1.566
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 4
Shares Outstanding 68,848,553
Shares Percent Shares Out 0.0432
Shares Short 2,973,072
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 2,842,884
Short Name OraSure Technologies, Inc.
Short Percent Of Float 0.0454
Short Ratio 3.93
Source Interval 15
State PA
Symbol OSUR
Target High Price 6.0
Target Low Price 3.5
Target Mean Price 4.75
Target Median Price 4.75
Total Cash 176,964,000
Total Cash Per Share 2.57
Total Debt 12,659,000
Total Revenue 113,015,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.05
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.05385
Two Hundred Day Average Change 1.2461503
Two Hundred Day Average Change Percent 0.40805876
Type Disp Equity
Volume 265,847
Website https://www.orasure.com
Zip 18,015